Core Laboratories Reports Q3 GAAP EPS of $0.12, Missing Analyst Estimates
Core Laboratories (NYSE: CLB) reported third-quarter financial results that featured a miss on earnings per share (EPS). The company posted a GAAP EPS of $0.12, falling short of consensus estimates by $0.03. Revenue for the quarter reached $132.1 million, which was in line with market expectations despite representing a 1.8% decline compared to the same period last year. The results highlight a slight contraction in top-line growth alongside earnings pressure.
Tickers: $CLB
Topics: EPS miss quarterly earnings revenue performance
Read the full article at Seeking Alpha
Part of the story Viking Therapeutics Reports Q3 GAAP EPS of -$1.55, Missing Estimates by $0.50 (3 articles)